Vaccines remain the safest strategy for avoiding hospitalizations, long-term health outcomes, and death. However, with several types of vaccines still being developed that vary in their mechanism of action comes the risk of associated adverse effects .
Researchers and doctors from the Eye Institute, Cleveland Clinic Abu Dhabi-UAE, have published a study in JAMA Opthalmology, where individuals presented with adverse ocular events following the administration of BBIBP-CorV, an inactivated COVID-19 vaccine. Study design Subjects included: o Those with ocular reactions within 15 days of the first dosage o Sample size: 7 patients (3 males, 4 females), 9 eyes o Age group – 30 to 55 years Tests conducted: o Snellen best-corrected visual acuity - converted to logMAR o Applanation tonometry o Biomicroscopic examination with indirect ophthalmoscopy o Color fundus photography o …
